Literature DB >> 7534045

CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease.

A Carbone, A Gloghini, H J Gruss, A Pinto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7534045      PMCID： PMC1869163     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  5 in total

Review 1.  The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Authors:  C A Smith; T Farrah; R G Goodwin
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

2.  CD40 expression in Hodgkin's disease.

Authors:  J T O'Grady; S Stewart; J Lowrey; S E Howie; A S Krajewski
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

Review 3.  The CD40 antigen and its ligand.

Authors:  J Banchereau; F Bazan; D Blanchard; F Brière; J P Galizzi; C van Kooten; Y J Liu; F Rousset; S Saeland
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 4.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

5.  Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease.

Authors:  H J Gruss; D Hirschstein; B Wright; D Ulrich; M A Caligiuri; M Barcos; L Strockbine; R J Armitage; S K Dower
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113
  5 in total
  3 in total

Review 1.  New molecular targets for treatment of lymphoma.

Authors:  Barbara Pro; Anas Younes
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

2.  Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.

Authors:  Michelle Fanale; Sarit Assouline; John Kuruvilla; Philippe Solal-Céligny; Dae S Heo; Gregor Verhoef; Paolo Corradini; Jeremy S Abramson; Fritz Offner; Andreas Engert; Martin J S Dyer; Daniel Carreon; Brett Ewald; Johan Baeck; Anas Younes; Arnold S Freedman
Journal:  Br J Haematol       Date:  2013-11-13       Impact factor: 6.998

Review 3.  The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints.

Authors:  Santosha Vardhana; Anas Younes
Journal:  Haematologica       Date:  2016-07       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.